Dr Nigel Burns joins Cell Medica
This article was originally published in Scrip
Executive Summary
Cell Medica (UK) has named Dr Nigel Burns chairman. He has more than 20 years' experience in the biotech industry, most recently as a senior executive of Cambridge Antibody Technology. Cell Medica is a clinical-stage cellular therapeutics company engaged in the development and delivery of cellular immunotherapy treatment strategies for infectious disease.
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.